1. Home
  2. AREB vs INBS Comparison

AREB vs INBS Comparison

Compare AREB & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AREB

American Rebel Holdings Inc.

HOLD

Current Price

$1.05

Market Cap

6.8M

Sector

Industrials

ML Signal

HOLD

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$0.56

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AREB
INBS
Founded
2014
2016
Country
United States
United States
Employees
N/A
55
Industry
Plastic Products
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8M
5.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AREB
INBS
Price
$1.05
$0.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
930.4K
148.5K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,014,691.00
$3,292,042.00
Revenue This Year
N/A
$778.48
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.26
52 Week Low
$0.90
$0.56
52 Week High
$1,835.00
$2.75

Technical Indicators

Market Signals
Indicator
AREB
INBS
Relative Strength Index (RSI) 42.62 29.32
Support Level $0.90 $0.68
Resistance Level $1.10 $0.75
Average True Range (ATR) 0.14 0.05
MACD 0.09 0.01
Stochastic Oscillator 34.09 1.28

Price Performance

Historical Comparison
AREB
INBS

About AREB American Rebel Holdings Inc.

American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Share on Social Networks: